Endotoxin removal: History of a mission

Blood Purification

Volumn 37, Issue SUPPL. 1, 2014, Pages 5-8

  Ronco, Claudio ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Lipopolysaccharide; Polymyxin B; Sepsis

Indexed keywords

ESCHERICHIA COLI ENDOTOXIN; LIPOPOLYSACCHARIDE; POLYMYXIN B; ENDOTOXIN;

ADSORPTION; ARTICLE; CLINICAL EFFECTIVENESS; CRITICALLY ILL PATIENT; DETOXIFICATION; ENDOTOXEMIA; HEMODYNAMICS; HEMOFILTRATION; HEMOPERFUSION; HUMAN; IMMUNOMODULATION; KIDNEY FUNCTION; LUNG FUNCTION; META ANALYSIS (TOPIC); MORTALITY; NONHUMAN; PATIENT SELECTION; PERSONALIZED MEDICINE; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPTIC SHOCK; BACTERIAL CELL WALL; BLOOD ANALYSIS; ENDOTOXIN DETECTION; EXTRACORPOREAL CIRCULATION; GRAM NEGATIVE BACTERIUM; PATHOGENESIS; REVIEW; SEPSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; GRAM-NEGATIVE BACTERIA; HEMOPERFUSION; HUMANS; LIPOPOLYSACCHARIDES; POLYMYXIN B; SEPSIS;

EID: 84893294145     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000356831     Document Type: Article

References (21)

1. Beutler B, Rietschel ET: Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3: 169-176.
2. Marshall JC, Foster D, Vincent JL, et al: Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004; 190: 527-534.
3. McCloskey RV, Straube RC, Sanders C, et al: Treatment of septic shock with human monoclonal antibody HA-1A: a randomized, doubleblind, placebo-controlled trial - CHESS Trial Study Group. Ann Intern Med 1994; 121: 1-5.
4. Angus DC, Birmingham MC, Balk RA, et al: E5 murine monoclonal antiendotoxin antibody in Gram-negative sepsis: a randomized controlled trial - E5 Study Investigators. JAMA 2000; 283: 1723-1730.
5. Opal SM, Laterre PF, Francois B, et al: Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 2013; 309: 1154-1162.
6. Thomas CJ, Gangadhar BP, Surolia N, et al: Kinetics and mechanism of the recognition of endotoxin by polymyxin B. J Am Chem Soc 1998; 120: 12428-12434.
7. Kwa AL, Tam VH, Falagas ME: Polymyxins: a review of the current status including recent developments. Ann Acad Med Singapore 2008; 37: 870-883.
8. Fiore B, Soncini M, Vesentini S, Penati A, Visconti G, Redaelli A: Multi-scale analysis of the toraymyxin adsorption cartridge. Part II: computational fluid-dynamic study. Int J Artif Organs 2006; 29: 251-260.
9. Vesentini S, Soncini M, Zaupa A, Silvestri V, Fiore GB, Redaelli A: Multi-scale analysis of the toraymyxin adsorption cartridge. Part I: molecular interaction of polymyxin B with endotoxins. Int J Artif Organs 2006; 29: 239-250.
10. Shoji H: Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003; 7: 108-114.
11. Sakai Y, et al: New extracorporeal blood purification devices for critical care medicine under development. Ther Plasmapheresis 1993; 12: 837-842.
12. Nishibori M, Takahashi HK, Katayama H, et al: Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Med Okayama 2009; 63: 65-69.
13. Abe S, Seo Y, Hayashi H, et al: Neutrophil adsorption by polymyxin B-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study. Blood Purif 2010; 29: 321-326.
14. Mitaka C, Tomita M: Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock. Shock 2011; 36: 332-338.
15. Nakamura T, Ushiyama C, Suzuki Y, et al: Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus . J Hosp Infect 2003; 53: 58-63.
16. Nakamura T, Ebihara I, Shoji H, et al: Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble Pselectin, platelet factor 4 and β-thrombo - globulin. Inflamm Res 1999; 48: 171-175.
17. Nemoto H, Nakamoto H, Okada H, et al: Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 2001; 19: 361-369.
18. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, Nakamura H, John S: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intraabdominal infection. Shock 2005; 23: 400-405.
19. Cruz DN, Perazella MA, Bellomo R, et al: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007; 11:R47.
20. Cruz DN, Antonelli M, Fumagalli R, et al: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009; 301: 2445-2452.
21. Zhou F, Peng Z, Murugan R, Kellum JA: Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 2013; 41:2209-2220.